133 related articles for article (PubMed ID: 2876407)
1. [HLA and multiple sclerosis].
Govaerts A
Pathol Biol (Paris); 1986 Jun; 34(6):738-40. PubMed ID: 2876407
[TBL] [Abstract][Full Text] [Related]
2. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA and multiple sclerosis.
Martin R; Vogt AB; Kropshofer H; Lichtenfels R
Behring Inst Mitt; 1994 Jul; (94):158-70. PubMed ID: 7998908
[TBL] [Abstract][Full Text] [Related]
4. HLA-DR-dependent variation of intrathecal IgG1 (Gm) allotype synthesis in multiple sclerosis.
Salier JP; Martin-Mondiere C; Sesboüé R; Daveau M; Goust JM; Govaerts A; Schuller E; Degos JD
J Immunol; 1985 Mar; 134(3):1551-4. PubMed ID: 3855432
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
[TBL] [Abstract][Full Text] [Related]
6. [Immunogenetics of multiple sclerosis].
Clanet M; Cambon-Thomsen A; Rascol A
Pathol Biol (Paris); 1987 Mar; 35(3):299-302. PubMed ID: 3295695
[TBL] [Abstract][Full Text] [Related]
7. [Familial predisposition to multiple sclerosis].
Turpin JC; Dubois D; Delasnerie-Laupretre N
Rev Neurol (Paris); 1986; 142(5):509-16. PubMed ID: 3787053
[TBL] [Abstract][Full Text] [Related]
8. HLA associations with multiple sclerosis in Sicily and Malta.
Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
[TBL] [Abstract][Full Text] [Related]
9. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B
Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
[TBL] [Abstract][Full Text] [Related]
11. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.
Ballerini C; Guerini FR; Rombolà G; Rosati E; Massacesi L; Ferrante P; Caputo D; Talamanca LF; Naldi P; Liguori M; Alizadeh M; Momigliano-Richiardi P; D'Alfonso S
J Neuroimmunol; 2004 May; 150(1-2):178-85. PubMed ID: 15081263
[TBL] [Abstract][Full Text] [Related]
12. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
13. Possible mechanisms for association of HLA antigens and disease.
Mittal KK
Prog Clin Biol Res; 1977; 16():39-51. PubMed ID: 198823
[No Abstract] [Full Text] [Related]
14. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR2 and white matter lesion distribution in MS.
Sepulcre J; Masdeu JC; Palacios R; Goñi J; Moreno B; Tainta M; Bejarano B; Villoslada P
J Neuroimaging; 2008 Jul; 18(3):328-31. PubMed ID: 18482373
[TBL] [Abstract][Full Text] [Related]
16. [Complement markers Bf and C4 in multiple sclerosis].
Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiology of multiple sclerosis].
Delasnerie-Lauprêtre N; Alpérovitch A
Rev Prat; 1991 Sep; 41(20):1884-7. PubMed ID: 1925370
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics of histocompatibility antigens distribution in patients with multiple sclerosis].
Shiralieva RK; Guseĭnova KA
Klin Med (Mosk); 1998; 76(1):19-20. PubMed ID: 9532908
[TBL] [Abstract][Full Text] [Related]
19. [Immunogenetic analysis of multiple sclerosis].
Govaerts A
Bull Mem Acad R Med Belg; 1983; 138(4):300-5. PubMed ID: 6640186
[No Abstract] [Full Text] [Related]
20. HLA-D typing with an association of Dw2 and absent immune responses towards herpes simplex (type i) antigen in multiple sclerosis.
Paty DW; Cousin HK; Stiller CR; Boucher DW; Furesz J; Warren KG; Marchuk L; Dossetor JB
Transplant Proc; 1977 Dec; 9(4):1845-8. PubMed ID: 203060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
